Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small Cell Carcinoma of Lung, TNM Stage 4”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03786692
What this trial is testing

Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

Who this might be right for
Non-Small Cell Carcinoma of Lung, TNM Stage 4
Fox Chase Cancer Center 107
Testing effectiveness (Phase 2)Ended earlyNCT02967133
What this trial is testing

Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer MetastaticNon-Small Cell Carcinoma of Lung, TNM Stage 4Nonsmall Cell Lung Cancer+1 more
Alliance Foundation Trials, LLC. 7
Not applicableStudy completedNCT04710459
What this trial is testing

Endobronchial Cryotherapy in Management of MEBO in Patients With Inoperable NSCLC

Who this might be right for
Non Small Cell Lung CancerNon-Small Cell Carcinoma of Lung, TNM Stage 4Bronchogenic Cancer
Mohamed Abdel Bary Ahmed Ibrahim 60
Large-scale testing (Phase 3)Study completedNCT04776083
What this trial is testing

Radiotherapy to the Primary in Metastatic Non-small Cell Lung Cancer Patients

Who this might be right for
Non-Small Cell Carcinoma of Lung, TNM Stage 4Radiation Therapy
Menoufia University 75
Early research (Phase 1)Ended earlyNCT02309892
What this trial is testing

A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Helix BioPharma Corporation 14
Large-scale testing (Phase 3)Active Not RecruitingNCT03774732
What this trial is testing

PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerNon Small Cell Lung Cancer MetastaticNon-Small Cell Carcinoma of Lung, TNM Stage 4
UNICANCER 327
Not applicableEnded earlyNCT05891197
What this trial is testing

A Biomarker Screening Protocol for Participants With Solid Tumors

Who this might be right for
Triple Negative Breast CancerNon-small Cell Lung CancerNon Small Cell Lung Cancer+19 more
Lyell Immunopharma, Inc. 10
Early research (Phase 1)Ended earlyNCT05274451
What this trial is testing

Investigate LYL797 in Adults With Solid Tumors

Who this might be right for
Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more
Lyell Immunopharma, Inc. 57
Large-scale testing (Phase 3)UnknownNCT03288870
What this trial is testing

Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS)

Who this might be right for
Non Small Cell Lung Cancer Stage IIIBNon-Small Cell Carcinoma of Lung, TNM Stage 4
Biocad 218
Not applicableUnknownNCT03605602
What this trial is testing

A Real World Study Based on NGS (TRUMPRWS)

Who this might be right for
Non-Small Cell Carcinoma of Lung, TNM Stage 4
Guangdong Association of Clinical Trials 2,700
Not applicableStudy completedNCT05372081
What this trial is testing

Clinical and Molecular Study With Digital Support of Patients With Inoperable Lung Cancer

Who this might be right for
Non-Small Cell Carcinoma of Lung, TNM Stage 4
Hellenic Cooperative Oncology Group 200
Testing effectiveness (Phase 2)Study completedNCT03406468
What this trial is testing

Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung Cancer

Who this might be right for
Non-Small Cell Carcinoma of Lung, TNM Stage 4
Maastricht Radiation Oncology 36
Not applicableLooking for participantsNCT03042221
What this trial is testing

Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy

Who this might be right for
Non-Small Cell Carcinoma of Lung, TNM Stage 4Non-Small Cell Lung CancerEGFR Gene Mutation+3 more
University of Colorado, Denver 100
Testing effectiveness (Phase 2)Ended earlyNCT04856176
What this trial is testing

Sargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaNon-Small Cell Carcinoma of Lung, TNM Stage 4
Tufts Medical Center 5